(MedPage Today) — While the introduction of novel therapies has led to substantial improvements in the outcomes of patients with newly diagnosed multiple myeloma, there remains a high-risk population of patients who experience early disease progression…
Source link : https://www.medpagetoday.com/spotlight/asco-mm/116504
Author :
Publish date : 2025-07-15 15:11:00
Copyright for syndicated content belongs to the linked Source.
